Home 2024
Archives
Moving past animal experiments to understand human neurological disease
Richard J. Miller, PhD, Professor Emeritus of Pharmacology at Northwestern University Feinberg School of Medicine, says that the belief monkeys and other animals are essential for performing translationally useful research for human neurological disease is outdated and incompatible with 21st-century science.
Understanding and supporting neurological conditions among the incarcerated
Samuel Han and Audrey Nath discuss neurological conditions among the incarcerated, who they argue are a medically underserved population.
Exploring neurological & mental brain disorders in Europe
European Brain Council provides a very helpful update on Brain disorders in Europe – neurological and mental alike.
CorTec’s Brain Interchange™ system: Revolutionizing brain therapy with closed-loop neuromodulation
CorTec’s Brain Interchange™ system offers closed-loop neuromodulation, revolutionizing brain therapy by precisely adapting treatment based on individual needs.
Peroxisomes, lipids, and neurodegeneration
Prof. Michael Schrader at the University of Exeter looks to understand the role of peroxisomes in human health and disease.
Fostering nonhuman primate (NHP) brain research without animal sacrifice
The MacBrain Resource Center (MBRC) at Yale University School of Medicine is positioning itself at the forefront of innovative ways to provide cost-effective means for scientists to conduct de novo nonhuman primate brain research with extant materials.
Psychedelic therapies are returning to psychiatry
Professor Erika Dyck, Canada Research Chair in History of Health & Social Justice at the University of Saskatchewan, looks to psychedelic therapies outside the pharmaceutical industry to aid mental illness.
Updating services for people with younger onset dementia and their caregivers
Researchers from the Jockey Club Centre for Positive Ageing analyse the services available for people with younger onset dementia, looking to improve the lives of those affected and their carers.
FMRI neurofeedback: Novel interventions for depression
Kymberly Young, an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine, discusses neurofeedback as a novel non-invasive intervention for depression.
The WATCH project: Tanycytes in health and disease
The WATCH project aims to elucidate how tanycytes mediate physiological processes by acting as gatekeepers between the brain and body, how their dysfunction is involved in various disorders and age-related impairments, and what can be done to prevent or correct these.
Focused ultrasound for major depressive disorder
Low-Intensity Focused Ultrasound (LIFU) is an emerging neuromodulation method for treating major depressive disorder which allows for non-invasive stimulation across the whole brain.
Remyelinating versus neuroprotective therapies for multiple sclerosis
Reducing clinical relapses and improving quality of life is at the heart of MS treatment; here Tara M. DeSilva explores the benefits of remyelinating versus neuroprotective therapies for tackling MS.
Neurodegeneration in multiple sclerosis: retinal imaging as a biomarker
Therapeutic strategies for multiple sclerosis reduce the number of relapses and improve quality of life early in the disease course, nevertheless, neurodegeneration ultimately gives rise to permanent disability.
How can Daoism benefit Western education?
Open Access Government speaks to Dr Tom Culham on the benefits of incorporating Daoism in Western education.